DLT Resolution (DLTI) 10-Q 21 Nov 17 2017 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Nov. 20, 2017
Document And Entity Information
Entity Registrant Name	HEMCARE HEALTH SERVICES INC.
Entity Central Index Key	1,420,368
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	Yes
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		123,225,211
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,017

Balance Sheets

Balance Sheets - USD ($)	Sep. 30, 2017	Dec. 31, 2016
ASSETS
Intangible assets	$ 55,000
Total assets	55,000
Current liabilities
Bank overdraft	7	7
Accounts payable and accrued liabilities	106,656	38,772
Dividends payable	25,448	25,448
Related party payables	49,544	39,599
Current notes payable	81,500	332,100
Derivative liability	68,793
Convertible notes payable, net of discounts of $0 and $6,916	4,900	23,784
Related party convertible notes payable, net of discounts $0 and $0		2,634
Total current liabilities	336,848	462,344
Related party notes payable, net of current portion	10,000
Notes payable, net of current portion	85,000
Total liabilities	431,848	462,344
Stockholders' deficit
Common stock, $0.001 par value; 275,000,000 shares authorized; 212,275,211 and 273,332,211 issued; 123,225,211 and 272,952,211 outstanding at September 30, 2017 and December 31, 2016	212,275	273,332
Additional paid in capital	2,902,463	2,613,165
Other comprehensive income	24	24
Treasury stock, 89,050,000 shares	(95,200)	(100)
Accumulated deficit	(3,421,410)	(3,348,765)
Total stockholders' deficit	(376,848)	(462,344)
Total liabilities and stockholders' deficit	55,000
Series A convertible preferred stock [Member]
Stockholders' deficit
Series A convertible preferred stock, $1.00 par value; 5,000,000 shares authorized, 25,000 and 0 issued and outstanding at September 30, 2017 and December 31, 2016	$ 25,000

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current liabilities
Convertible notes payable, net of discounts	$ 0	$ 6,916
Convertible notes payable, net of discounts related parties	$ 0	$ 0
Stockholders' deficit
Convertible preferred stock; par value	$ 0.001	$ 0.001
Common stock; par value	$ 0.001	$ 0.001
Common stock; shares authorized	275,000,000	275,000,000
Common stock; shares issued	212,275,211	273,332,211
Common stock; shares outstanding	123,225,211	272,952,211
Treasury stock shares	89,050,000	89,050,000
Series A convertible preferred stock [Member]
Stockholders' deficit
Convertible preferred stock; par value	$ 1	$ 1
Convertible preferred stock; shares authorized	5,000,000	5,000,000
Convertible preferred stock; shares issued	25,000	0
Convertible preferred stock; shares outstanding	25,000	0
Common stock; par value	$ 0.10	$ 0.10
Common stock; shares issued		131,170,000

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Statements Of Operations
Revenue
Operating expenses
General and administrative	579	1,162	6,419	8,320
Professional fees	3,121	1,228	14,879	17,116
Total operating expenses	3,700	2,390	21,298	25,436
Other income (expense)
Discharge of indebtedness			26,306
Loss on change in fair market value of derivative liability	(63,886)		(63,445)
Interest expense	(5,218)	(7,994)	(14,208)	(44,525)
Total other income (expense)	(69,104)	(7,994)	(51,347)	(44,525)
Net income (loss)	(72,804)	(10,384)	(72,645)	(69,961)
Preferred stock dividends declared		(1,591)		(6,448)
Net income (loss) attributable to common shareholders	$ (72,804)	$ (11,975)	$ (72,645)	$ (76,409)
Basic and diluted loss per common share	$ 0	$ 0	$ 0	$ 0
Weighted average shares outstanding - basic	153,917,570	190,258,081	200,403,394	158,118,401

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities
Net income (loss) from operations	$ (72,645)	$ (69,961)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Forgiveness of debt	(26,306)
Amortization of debt discounts	4,900	28,508
Loss on change in fair market value of derivative liability	63,445
Excess fair market value of derivative liability charged to interest	448
Expenses paid on behalf of the company by related parties	6,420
Changes in operating assets and liabilities
Prepaid expenses		2,252
Accounts payable and accrued liabilities	23,738	12,260
Net cash used in operating activities		(26,941)
Net cash used in investing activities
Cash flows from financing activities
Proceeds from bank overdraft		7
Repayments of related party convertible notes payable		(8,000)
Proceeds from convertible notes payable		17,100
Repayments of convertible notes payable		(2,500)
Net cash used in financing activities		6,607
Net change in cash		(20,334)
Cash at beginning of period		20,334
Cash at end of period
Supplemental cash flow information
Cash paid for interest
Cash paid for income taxes
Non-cash investing and financing activities
Forgiveness of related party convertible note payable	2,634
Forgiveness of related party interest payable	606
Forgiveness of convertible note payable	23,783
Forgiveness of note payable	600
Forgiveness of interest payable	1,923
Common shares issued in exchange for note payable principal	250,000
Account payable entered into for intangible asset	55,000
Accounts payable paid by related party	3,425
Accounts payable paid by convertible noteholder	4,900
Related party note payable entered into for purchase of treasury stock	10,000
Notes payable entered into for purchase of treasury stock	85,000
Related party advance for purchase of treasury stock	100
Preferred dividend declared		6,448
Preferred stock issued for repayment of note payable		18,500
Preferred stock issued for repayment of accrued interest payable		$ 31,500

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Note 1 - Basis of Presentation	The accompanying unaudited interim financial statements of Hemcare Health Services Inc. (formerly NSU Resources, Inc.) (collectively referred to herein as “Hemcare Health Services”, “Hemcare”, or the “Company”), have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements for the period ended December 31, 2016 and notes thereto contained in the Company’s Form 10-K filed with the SEC. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2016 as reported in the form 10-K have been omitted.

Going Concern

Going Concern	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Note 2 - Going Concern	The Company had an accumulated deficit of $3,421,410 and a working capital deficit of $336,848 as of September 30, 2017 and had no revenues. These matters raise substantial doubt about the Company’s ability to continue as a going concern. Continuation of the Company’s existence depends upon its ability to obtain additional capital. Management’s plans in regards to this matter include raising additional equity financing and borrowing funds under a private credit facility and/or other credit sources. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Note 3 - Significant Accounting Policies	Use of Estimates The preparation of financial statements, in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Cash Equivalents The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents. Prior Period Conformity The Company has reclassified balances in the prior period financial statements for conformity with the current period for comparison purposes. Income Taxes The Company accounts for income taxes under the asset and liability method, where deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. At September 30, 2017, there were no uncertain tax positions that require accrual. Intangible Asset During the nine months ended September 30, 2017, the Company entered into an agreement whereby a third party would build a web portal as part of executing our business plan. Through September 30, 2017, we had incurred $55,000 of costs to build the portal which are included in accounts payable as of September 30. The portal has yet to be launched and as such there has been no amortization recorded or impairment as of September 30, 2017. Net Income (Loss) Per Share Basic loss per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. As of September 30, 2017, there was a convertible note outstanding that could convert to a total of 490,000 common shares. Because of the net loss incurred during the three and nine months ended September 30, 2017, the impacts of dilutive instruments would have been anti-dilutive for the period presented and have been excluded from loss per share calculations. There were no potentially dilutive instruments outstanding at September 30, 2016. Derivative Liabilities The Company records a debt discount related to the issuance of convertible debts that have conversion features at adjustable rates. The debt discount for the convertible instruments is recognized and measured by allocating a portion of the proceeds as an increase in additional paid-in capital and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion features. The debt discount will be accreted by recording additional non-cash gains and losses related to the change in fair market values of derivative liabilities over the life of the convertible notes. Recently Issued Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board ("FASB") or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Note 4 - Related Party Transactions	No salaries were paid to directors or executives during the periods ended September 30, 2017 or 2016. On January 31, 2017, the Company entered into a mutual release agreement with a related party with which there was an outstanding convertible note of $2,634 and outstanding accrued interest of $1,923. The agreement forgave the outstanding payables and they were written to $0 against additional paid in capital on the date of the agreement. During the nine months ended September 30, 2017, a related party paid $6,419 of expenses, $3,426 of outstanding payables on behalf of the company and $100 to repurchase treasury stock on behalf of the Company. The advances are due on demand and are included in current liabilities as a result. There was $49,544 and $39,599 due to related parties as of September 30, 2017 and December 31, 2016. On August 1, 2017, the Company entered into a $10,000 note payable with a related party to purchase 3,000,000 common shares as treasury stock. The note requires payments of $5,000 on July 1, 2019, $2,500 on July 1, 2020 and $2,500 plus all accrued interest on July 31, 2022 and accrues interest at 3% per annum. There was $10,000 of principal and accrued interest of $49 due as of September 30, 2017.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Note 5 - Stockholders' Equity	Series A Convertible Preferred Stock The Company is authorized to issue up to 5,000,000 shares of Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock can be converted to common shares at the option of the holder at a rate equal to $0.10 per share. During the nine months ended September 30, 2017, the Company issued 25,000 shares of Series A Convertible Preferred Stock in exchange for 2,417,000 shares of common stock. There were 25,000 and 0 shares of series A convertible preferred stock issued and outstanding as of September 30, 2017 and December 31, 2016. Additionally, the Company had accrued dividends payable on series A convertible preferred stock totaling $25,448 at September 30, 2017 and December 31, 2016. Common Stock On March 2, 2015, the Company effected a 1:50 reverse stock split. The effects of the reverse split are shown retroactively in these financial statements. The authorized common stock of the Company consists of 275,000,000 shares and carries a par value of $0.001. During the year ended December 31, 2014, the Company bought back 380,000 post-split shares of common stock into treasury from a former officer for $100. The shares are being carried as treasury shares as reflected on the balance sheet. During the year ended December 31, 2016, the Company issued 131,170,000 common shares for the conversion of 131,170 shares of Series A Preferred Stock. There was no gain or loss on this conversion During the nine months ended September 30, 2017, the Company entered into agreements with various individuals and entities to cancel a total of 71,140,000 shares of its common stock; entered into $10,000 of related party notes payable for the purchase of 3,000,000 shares of common stock; entered into $85,000 of notes payable for the purchase of 65,670,000 shares of common stock; purchased 20,000,000 common shares through an advance from a related party and 12,500,000 common shares in exchange for $250,000 of outstanding note principal. There were 212,275,211 and 273,332,211 common shares issued and 123,225,211 and 272,952,211 shares outstanding as of September 30, 2017 and December 31, 2016, respectively.

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Note 6 - Notes Payable	During the year ended December 31, 2015, the Company entered into a note payable with an unrelated party as a settlement for payment of consulting services provided valued at $350,000. The note carries interest of 9% compounded annually and is due on November 19, 2016. During the year ended December 31, 2016, the Company issued 50,000 shares of series A convertible preferred stock as repayment of $31,500 of accrued interest and $18,500 of outstanding principal. During the nine months ended September 30, 2017, the Company issued 12,500,000 shares of common stock in exchange for $250,000 of principal and extended the maturity date to January 26, 2018. There was $81,500 and $331,500 of principal and $17,696 and $10,299 of accrued interest due as of September 30, 2017 and December 31, 2016. Accrued interest payable is included in “accounts payable and accrued liabilities” on the balance sheet. During the nine months ended September 30, 2017, the Company entered into an agreement with a noteholder to forgive a $600 outstanding note payable. The Company wrote the balance to $0 as a discharge of indebtedness on the statements of operations. There was $0 and $600 outstanding as of September 30, 2017 and December 31, 2016. On August 1, 2017, the Company entered into a note payable for $75,000 to purchase 52,500,000 shares of common stock. The note requires payments of $25,000 on July 1, 2019, $25,000 on July 1, 2020 and $25,0500 plus all accrued interest on July 31, 2022 and accrues interest at 3% per annum. There was $75,000 of principal and accrued interest of $370 due as of September 30, 2017. On August 1, 2017, the Company entered into a note payable for $10,000 to purchase 13,170,000 shares of common stock. The note requires payments of $5,000 on July 1, 2019, $2,500 on July 1, 2020 and $2,500 plus all accrued interest on July 31, 2022 and accrues interest at 3% per annum. There was $10,000 of principal and accrued interest of $49 due as of September 30, 2017.

Convertible Notes Payable

Convertible Notes Payable	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Note 7 - Convertible Notes Payable	During the nine months ended September 30, 2017, the Company entered into an agreement with a convertible noteholder for the extinguishment the outstanding principal of the convertible note of $24,383 and interest of $1,923 for a total $26,306. There was $0 and $23,784 net of discounts outstanding at September 30, 2017 and December 31, 2016. On May 22, 2017, the Company entered into a convertible note payable for $4,900 which was paid to third parties on our behalf resulting in net cash proceeds to the Company of $0. The note carries interest at a rate of 10% per annum and is due on August 20, 2017. The note and accrued interest is convertible into common stock of the Company at a rate equal to a 50% discount from the stock price on the date of conversion if converted within the first 90 days and the lesser of a 50% discount from the stock price on the date of conversion and $0.01 if converted after 90 days. There was $4,900 of principal, debt discounts of $0 and accrued interest totaling $994 outstanding as of September 30, 2017.

Derivative Liability

Derivative Liability	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Note 8 - Derivative Liability	As discussed in Note 3, on a recurring basis, we measure certain financial assets and liabilities based upon the fair value hierarchy. The following table presents information about the Company’s liabilities measured at fair value as of September 30, 2017 and December 31, 2016: Level 1 Level 2 Level 3 Fair Value at September 30, 2017 Liabilities Derivative Liability $ - $ 68,793 $ - $ 68,793 Level 1 Level 2 Level 3 Fair Value at December 31, 2016 Liabilities Derivative Liability $ - $ - $ - $ - As of September 30, 2017, the Company had a $68,793 derivative liability balance on the balance sheet and recorded a loss from derivative liability fair value adjustment of $63,886 and $63,445 during the three and nine months ended September 30, 2017. The Company assessed its outstanding convertible notes payable as summarized in Note 7 – Convertible Notes Payable ASC 920, Fair Value Measurements and Disclosures ASC 825, Financial Instruments. Utilizing Level 2 Inputs, the Company recorded fair market value adjustments related to convertible notes payable for the nine months ended September 30, 2017 and 2016 of $63,445 and $0, respectively. The fair market value adjustments were calculated utilizing the Black-Sholes method using the following assumptions: risk free rates of 1.20%, dividend yield of 0%, expected lives of 0.50 years, and volatility of 189%. A summary of the activity of the derivative liability is shown below: Balance at December 31, 2016 $ - Derivative liabilities recorded 5,348 Change due to note conversion - Fair value adjustment 63,445 Balance at September 30, 2017 $ 68,793

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Note 9 - Commitments and Contingencies	During the year ended December 31, 2015, the Company issued a total of 100,000 shares of series A convertible preferred stock in exchange for a prepayment of royalties and 40 complete Ultroid systems. Additionally, as discussed in Note 6, the Company entered into two separate convertible notes payable with an unrelated party. These transactions were not approved by unanimous board consent through the Company’s normal approval procedures. As such, the Company may challenge the validity of these agreements after additional review of the relevant details.

Significant Accounting Polici15

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2017
Significant Accounting Policies Policies
Use of Estimates	The preparation of financial statements, in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Cash Equivalents	The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.
Prior Period Conformity	The Company has reclassified balances in the prior period financial statements for conformity with the current period for comparison purposes.
Income taxes	The Company accounts for income taxes under the asset and liability method, where deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. At September 30, 2017, there were no uncertain tax positions that require accrual.
Intangible Asset	During the nine months ended September 30, 2017, the Company entered into an agreement whereby a third party would build a web portal as part of executing our business plan. Through September 30, 2017, we had incurred $55,000 of costs to build the portal which are included in accounts payable as of September 30. The portal has yet to be launched and as such there has been no amortization recorded or impairment as of September 30, 2017.
Net Income (Loss) Per Share	Basic loss per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share is computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. As of September 30, 2017, there was a convertible note outstanding that could convert to a total of 490,000 common shares. Because of the net loss incurred during the three and nine months ended September 30, 2017, the impacts of dilutive instruments would have been anti-dilutive for the period presented and have been excluded from loss per share calculations. There were no potentially dilutive instruments outstanding at September 30, 2016.
Derivative Liabilities	The Company records a debt discount related to the issuance of convertible debts that have conversion features at adjustable rates. The debt discount for the convertible instruments is recognized and measured by allocating a portion of the proceeds as an increase in additional paid-in capital and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion features. The debt discount will be accreted by recording additional non-cash gains and losses related to the change in fair market values of derivative liabilities over the life of the convertible notes.
Recent Accounting Pronouncements	From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board ("FASB") or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our financial position or results of operations upon adoption.

Derivative Liability (Tables)

Derivative Liability (Tables)	9 Months Ended
	Sep. 30, 2017
Derivative Liability Tables
Schedule of fair value measured	Level 1 Level 2 Level 3 Fair Value at September 30, 2017 Liabilities Derivative Liability $ - $ 68,793 $ - $ 68,793 Level 1 Level 2 Level 3 Fair Value at December 31, 2016 Liabilities Derivative Liability $ - $ - $ - $ -
Summary of activity of derivative liability	Balance at December 31, 2016 $ - Derivative liabilities recorded 5,348 Change due to note conversion - Fair value adjustment 63,445 Balance at September 30, 2017 $ 68,793

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Going Concern Details Narrative
Working capital deficit	$ (336,848)
Accumulated deficit	$ (3,421,410)	$ (3,348,765)

Significant Accounting Polici18

Significant Accounting Policies (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Account payable entered into for intangible asset	$ 55,000
Convertible note [Member]
Shares reserved for future issuance	490,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Aug. 01, 2017	Jan. 31, 2017	Dec. 31, 2016
Accrued interest	$ 49		$ 49			$ 1,923	$ 10,299
Proceeds from related party loans			3,426
Related party convertible notes payable						2,634	2,634
Due to related party	49,544		49,544				39,599
Additional paid in capital	2,902,463		2,902,463			$ 0	2,613,165
Related party expenses	579	$ 1,162	6,419	$ 8,320
Treasury stock	(95,200)		(95,200)				(100)
Related party notes payable	10,000		10,000		$ 10,000
Treasury stock common stock					3,000,000
Notes prinicipal Payments	10,000		10,000
On August 1, 2017 [Member]
Accrued interest	$ 49		$ 49
Accrued interest decription			The note requires payments of $5,000 on July 1, 2019, $2,500 on July 1, 2020 and $2,500 plus all accrued interest on July 31, 2022 and accrues interest at 3% per annum.

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	Mar. 02, 2015	Sep. 30, 2017	Dec. 31, 2016	Dec. 31, 2014
Treasury stock shares		89,050,000	89,050,000
Dividends payable		$ 25,448	$ 25,448
Common stock; shares authorized		275,000,000	275,000,000
Common stock; shares issued		212,275,211	273,332,211
Common stock; shares outstanding		123,225,211	272,952,211
Common stock par value		$ 0.001	$ 0.001
Reverse stock split	1:50
Treasury stock		$ 95,200	$ 100
Common stock shares cancellable under agreement		71,140,000
Common stock shares issued in exchange of notes payable, shares		3,000,000
Common stock shares issued in exchange of notes payable, amount		$ 10,000
Exchange shares of common stock		12,500,000
Outstanding note principal amount		$ 250,000
Related party [Member]
Common stock shares issued in exchange of notes payable, shares		20,000,000
Notes Payable [Member]
Common stock shares issued in exchange of notes payable, shares		65,670,000
Common stock shares issued in exchange of notes payable, amount		$ 85,000
Former officer [Member]
Treasury stock				$ 100
Former officer [Member] | Common Stock
Treasury stock shares				380,000
Series A convertible preferred stock [Member]
Converted shares		2,417,000	131,170
Convertible preferred stock; shares authorized		5,000,000	5,000,000
Convertible preferred stock; shares issued		25,000	0
Convertible preferred stock; shares outstanding		25,000	0
Common stock; shares issued			131,170,000
Common stock par value		$ 0.10	$ 0.10

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended		12 Months Ended
	May 22, 2017	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Dec. 31, 2015	Jan. 31, 2017
Accrued interest		$ 49		$ 10,299		$ 1,923
Convertible note payable	$ 4,900	$ 4,900			$ 350,000
Interest rate	10.00%				9.00%
Debt due date	Aug. 20, 2017				Nov. 19, 2016
Exchange shares of common stock		12,500,000
Outstanding note principal amount		$ 250,000
Maturity date		Jan. 26, 2018
Current notes payable		$ 81,500		332,100
Current notes payable net of forgiveness				331,500
Forgiveness of note payable		600
Write off other income		0
Notes Payable outstanding amount		$ 0		$ 600
Common stock shares issued in exchange of notes payable, shares		3,000,000
Series A convertible preferred stock [Member]
Share issued				50,000
Repayment of accrued interest				$ 31,500
Repayment of outstanding principal				$ 18,500
On August 1, 2017 One [Member]
Accrued interest		$ 370
Convertible note payable		$ 75,000
Common stock shares issued in exchange of notes payable, shares		52,500,000
Accrued interest decription		The note requires payments of $25,000 on July 1, 2019, $25,000 on July 1, 2020 and $25,0500 plus all accrued interest on July 31, 2022 and accrues interest at 3% per annum
On August 1, 2017 [Member]
Accrued interest		$ 49
Convertible note payable		$ 10,000
Common stock shares issued in exchange of notes payable, shares		13,170,000
Accrued interest decription		The note requires payments of $5,000 on July 1, 2019, $2,500 on July 1, 2020 and $2,500 plus all accrued interest on July 31, 2022 and accrues interest at 3% per annum.

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended		12 Months Ended
	May 22, 2017	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2015	Dec. 31, 2016
Convertible Notes Payable Details Narrative
Extinguishment of debt, Amount		$ 24,383
Forgiveness of interest payable		1,923
Forgiveness of debt		26,306
Convertible notes payable, net of discounts		4,900			$ 23,784
Convertible note payable	$ 4,900	4,900		$ 350,000
Net cash proceeds	$ 0
Interest rate	10.00%			9.00%
Maturity date	Aug. 20, 2017			Nov. 19, 2016
Description of common stock conversion	The note and accrued interest is convertible into common stock of the Company at a rate equal to a 50% discount from the stock price on the date of conversion if converted within the first 90 days and the lesser of a 50% discount from the stock price on the date of conversion and $0.01 if converted after 90 days.
Accrued interest		994
Debt discounts		$ 0			$ 6,916

Derivative Liability (Details)

Derivative Liability (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Liabilities
Derivative Liability	$ 68,793
Fair Value, Inputs, Level 1 [Member]
Liabilities
Derivative Liability
Fair Value, Inputs, Level 2 [Member]
Liabilities
Derivative Liability	68,793
Fair Value, Inputs, Level 3 [Member]
Liabilities
Derivative Liability

Derivative Liability (Details 1

Derivative Liability (Details 1) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Derivative Liability Details 1
Balance at December 31, 2016
Derivative liabilities recorded			5,348
Change due to note conversion
Fair value adjustment	$ 63,886		63,445
Balance at September 30, 2017	$ 68,793		$ 68,793

Derivative Liability (Details N

Derivative Liability (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Derivative liability	$ 68,793		$ 68,793
Loss on change in fair market value of derivative liability	(63,886)		$ (63,445)
Risk free rates			1.20%
Dividend yield			0.00%
Expected lives			6 months
Volatility			189.00%
Fair Value, Inputs, Level 2 [Member]
Derivative liability	$ 68,793		$ 68,793
Loss on change in fair market value of derivative liability			$ 63,445	$ 0

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - Series A convertible preferred stock [Member]	12 Months Ended
	Dec. 31, 2015Number / Systemshares
Number of Ultroid systems | Number / System	40
Shares issued | shares	100,000